greeksoup/ stock research

CME Group (CME) FY2020 results: revenue $4.9 billion, up 0.3% on the year

CME Group Inc. (CME) reported revenue of $4.9 billion for fiscal 2020, the year ended 31 December 2020, up 0.3% on the year before. Net income was $2.1 billion, down 0.5%, and diluted earnings per share $5.87. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2021.

Revenue
$4.9 billion
+0.3% on the year
FY2013FY2020
Operating margin
54.0%
53.2% a year earlier
FY2013FY2020
Net income
$2.1 billion
-0.5% on the year
FY2013FY2020
Diluted EPS
$5.87
-0.7% on the year
FY2013FY2020

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2020FY2019FY2018On the yearLast 8 years
Revenue4,8844,8684,309+0.3%
Operating income2,6372,5882,608+1.9%
Operating margin54.0%53.2%60.5%
Pre-tax income2,7222,6902,778+1.2%
Income tax616574814+7.3%
Effective tax rate22.6%21.3%29.3%
Net income2,1052,1161,962-0.5%
Net margin43.1%43.5%45.5%
Diluted EPS$5.87$5.91$5.71-0.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2020FY2019FY2018On the yearLast 8 years
Operating cash flow2,7162,6732,441+1.6%
Capital expenditure198246117-19.6%
Free cash flow2,5182,4272,324+3.7%
Free cash flow margin51.6%49.9%53.9%
Cash from investing-176-153-1,890
Cash from financing47,247-2,341-1,080
Depreciation and amortisation153159119-3.4%
Share-based compensation96.073.196.5+31.3%
Dividends paid2,1101,6962,150+24.4%
Dividend per share$5.90$5.50$4.55+7.3%
Diluted shares, weighted359m358m344m+0.1%

Balance sheet

$ millionFY2020FY2019FY2018On the yearLast 8 years
Shareholders' equity26,32026,12925,918+0.7%
Non-controlling interest31.630.446.8+3.9%
Short-term borrowings0.00.0n/a
Debt3,4443,7434,401-8.0%
Operating lease liabilities492515n/a-4.4%
Finance lease liabilities83.891.5n/a-8.4%
Other liabilities94,28844,70647,109+110.9%
Total liabilities and equity124,66075,21577,476+65.7%
Fixed assets579544449+6.5%
Goodwill10,79910,74210,805+0.5%
Intangible assets4,8655,1185,500-4.9%
Investments10183.272.9+21.3%
Trading assets82.666.152.7+25.0%
Cash and equivalents1,6331,5511,374+5.3%
Receivables461492553-6.2%
Other assets106,13856,61958,668+87.5%
Total assets124,66075,21577,476+65.7%

10-K for the year ended 31 December 2020, filed 26 February 2021: the filing.